Ames R P, Hill P
Am J Med. 1976 Nov;61(5):748-57. doi: 10.1016/0002-9343(76)90156-x.
In a study attempting to improve coronary risk status, serum cholesterol and triglyceride levels were measured before and during treatment of 74 patients with mild primary hypertension. In 35 patients there was a satisfactory reduction in elevated blood pressure levels with diet therapy alone. In the remaining 39 patients a diuretic drug was required in addition to the diet. Diet therapy alone was followed by a decrease of 11 mg/100 ml in mean serum cholesterol (p less than 0.01 versus pretreatment value) and no change in serum triglyceride. The sue of diuretics was accompanied by an average increase of 11 mg/100 ml in serum cholesterol and of 34 mg/100 ml in serum triglyceride (p less than 0.01 versus pretreatment level for both). In a subgroup of 21 patients with greatest elevations in lipid levels during the administration of diuretics, little improvement in coronary risk status occurred because the increase in serum cholesterol balanced the decrease in systolic blood pressure, according to Framingham risk tables. If the level of serum lipids is a factor in the pathogenesis of coronary atherosclerosis then the observed effect of diuretic drugs to elevate serum cholesterol and triglyceride levels may explain, in part, the continuing high rate of occurrence of myocardial infarction during the treatment of hypertension.
在一项旨在改善冠状动脉风险状况的研究中,对74例轻度原发性高血压患者在治疗前及治疗期间测量了血清胆固醇和甘油三酯水平。35例患者仅通过饮食疗法就使升高的血压水平得到了满意的降低。其余39例患者除饮食外还需要使用利尿剂。仅采用饮食疗法后,平均血清胆固醇降低了11mg/100ml(与治疗前值相比,p<0.01),血清甘油三酯无变化。使用利尿剂后,血清胆固醇平均升高11mg/100ml,血清甘油三酯平均升高34mg/100ml(两者与治疗前水平相比,p均<0.01)。在使用利尿剂期间血脂水平升高最明显的21例患者亚组中,根据弗雷明汉风险表,冠状动脉风险状况几乎没有改善,因为血清胆固醇的升高抵消了收缩压的降低。如果血清脂质水平是冠状动脉粥样硬化发病机制中的一个因素,那么利尿剂药物升高血清胆固醇和甘油三酯水平的观察到的效应可能部分解释了高血压治疗期间心肌梗死持续高发的原因。